FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

Published on: 

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

Related Content:

Bio/Pharma BusinessBiologic DrugsManufacturingVaccinesDosage Forms
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
A Look at the Impact of Industry Trends on Sensor Technologies (INTERPHEX 2024)
Single-Use Technologies Reinforce Fluid-Handling Workflows (INTERPHEX 2024)